52 related articles for article (PubMed ID: 16764700)
1. mRNA cytokine profile in peripheral blood cells from chronic hepatitis C virus (HCV)-infected patients: effects of interferon-alpha (IFN-alpha) treatment.
Shapiro S; Gershtein V; Elias N; Zuckerman E; Salman N; Lahat N
Clin Exp Immunol; 1998 Oct; 114(1):55-60. PubMed ID: 9764603
[TBL] [Abstract][Full Text] [Related]
2. HCV-specific cytokine induction in monocytes of patients with different outcomes of hepatitis C.
Woitas RP; Petersen U; Moshage D; Brackmann HH; Matz B; Sauerbruch T; Spengler U
World J Gastroenterol; 2002 Jun; 8(3):562-6. PubMed ID: 12046093
[TBL] [Abstract][Full Text] [Related]
3. Exploring the Impact of Different Inflammatory Cytokines on Hepatitis C Virus Infection.
Bader El Din NG; Farouk S
J Interferon Cytokine Res; 2024 Jun; 44(6):233-243. PubMed ID: 38563804
[TBL] [Abstract][Full Text] [Related]
4. Pentoxifylline Alone or in Combination with Gentamicin or Vancomycin Inhibits Live Microbe-Induced Proinflammatory Cytokine Production in Human Cord Blood and Cord Blood Monocytes
Speer EM; Diago-Navarro E; Ozog LS; Dowling DJ; Hou W; Raheel M; Fries BC; Levy O
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30275087
[TBL] [Abstract][Full Text] [Related]
5. Low Mannose Binding Lectin, but Not L-Ficolin, Is Associated With Spontaneous Clearance of Hepatitis C Virus After Infection.
Zhang J; Chen N; Chen Z; Liu Y; Zheng K; Qiu Y; Zhang N; Zhu J; Yu H; He Q
Front Immunol; 2020; 11():587669. PubMed ID: 33262767
[TBL] [Abstract][Full Text] [Related]
6. A Review on "IL-1 Receptor Antagonist Plus Pentoxifylline and Zinc for Severe Alcohol-Associated Hepatitis".
Anikhindi S; Anikhindi A; Kumar A; Arora A
J Clin Exp Hepatol; 2023; 13(3):533-535. PubMed ID: 37250885
[No Abstract] [Full Text] [Related]
7. Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double-blind, randomized, placebo-controlled trial.
Abdallah MS; Mosalam EM; Hassan A; Ramadan AN; Omara-Reda H; Zidan AA; Samman WA; El-Berri EI
CNS Neurosci Ther; 2023 Jan; 29(1):354-364. PubMed ID: 36341700
[TBL] [Abstract][Full Text] [Related]
8. Pentoxifylline in the Treatment of Cutaneous Leishmaniasis: A Randomized Clinical Trial in Colombia.
Castro MDM; Cossio A; Navas A; Fernandez O; Valderrama L; Cuervo-Pardo L; Marquez-Oñate R; Gómez MA; Saravia NG
Pathogens; 2022 Mar; 11(3):. PubMed ID: 35335703
[TBL] [Abstract][Full Text] [Related]
9. Co-infecting pathogens can contribute to inflammatory responses and severe symptoms in COVID-19.
Chen L; Shen L; Wu W; Guan W; Zhou J; Luo G; Chen Q; Zhou H; Deng Z; Chen Y; Zhao W; Jin W; Qiu M; Zheng Q; Wang Y; Liu C; Bai X; Guo D; Holmes EC; Zhong N; Shi M; Yang Z
J Thorac Dis; 2022 Feb; 14(2):355-370. PubMed ID: 35280492
[TBL] [Abstract][Full Text] [Related]
10. Tuberculosis and viral hepatitis infection in Eastern Europe, Asia, and Latin America: impact of tumor necrosis factor-α inhibitors in clinical practice.
Chen YH; de Carvalho HM; Kalyoncu U; Llamado LJQ; Solano G; Pedersen R; Lukina G; Lichauco JJ; Vasilescu RS
Biologics; 2018; 12():1-9. PubMed ID: 29391775
[TBL] [Abstract][Full Text] [Related]
11. Pentoxifylline for vascular health: a brief review of the literature.
McCarty MF; O'Keefe JH; DiNicolantonio JJ
Open Heart; 2016; 3(1):e000365. PubMed ID: 26870389
[TBL] [Abstract][Full Text] [Related]
12. Ex vivo host and parasite response to antileishmanial drugs and immunomodulators.
Gonzalez-Fajardo L; Fernández OL; McMahon-Pratt D; Saravia NG
PLoS Negl Trop Dis; 2015 May; 9(5):e0003820. PubMed ID: 26024228
[TBL] [Abstract][Full Text] [Related]
13. Modulation of radiation-induced oral mucositis by pentoxifylline: preclinical studies.
Gruber S; Schmidt M; Bozsaky E; Wolfram K; Haagen J; Habelt B; Puttrich M; Dörr W
Strahlenther Onkol; 2015 Mar; 191(3):242-7. PubMed ID: 25351168
[TBL] [Abstract][Full Text] [Related]
14. Clinical and immunological outcome in cutaneous leishmaniasis patients treated with pentoxifylline.
Brito G; Dourado M; Polari L; Celestino D; Carvalho LP; Queiroz A; Carvalho EM; Machado PR; Passos S
Am J Trop Med Hyg; 2014 Apr; 90(4):617-20. PubMed ID: 24567316
[TBL] [Abstract][Full Text] [Related]
15. Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations.
Zampino R; Marrone A; Restivo L; Guerrera B; Sellitto A; Rinaldi L; Romano C; Adinolfi LE
World J Hepatol; 2013 Oct; 5(10):528-40. PubMed ID: 24179612
[TBL] [Abstract][Full Text] [Related]
16. Japanese Encephalitis Vaccines.
McArthur MA; Holbrook MR
J Bioterror Biodef; 2011 Sep; S1():2. PubMed ID: 23125946
[TBL] [Abstract][Full Text] [Related]
17. Impact of pentoxifylline and vitamin e on ribavirin-induced haemolytic anaemia in chronic hepatitis C patients: an egyptian survey.
Assem M; Yousri M
Int J Hepatol; 2011; 2011():530949. PubMed ID: 21994862
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of several therapatic agents on hepatic damage induced by acute experimental pancreatitis.
Eşrefoğlu M; Gül M; Turan F
Dig Dis Sci; 2008 May; 53(5):1303-10. PubMed ID: 17934852
[TBL] [Abstract][Full Text] [Related]
19. Effect of pentoxifylline on levels of pro-inflammatory cytokines during chronic hepatitis C.
Gutierrez-Reyes G; Lopez-Ortal P; Sixtos S; Cruz S; Ramirez-Iglesias MT; Gutierrez-Ruiz MC; Sanchez-Avila F; Roldan E; Vargas-Vorackova F; Kershenobich D
Scand J Immunol; 2006 Jun; 63(6):461-7. PubMed ID: 16764700
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
